ASIT BIOTECH: On track to deliver key phase III readout by YE19 | CORPORATE | EUR4,5(+269%)
ASIT BIOTECH - CORPORATE | EUR4,5(+269%)On track to deliver key phase III readout by YE19
Phase III results in mid-December 2019
Staffing of key CMO role in preparation for EU filling
Cash runway to be extended to Q2 2020 upon phase III success
Asit Biotech SA. Asit Biotech SA, formerly Biotech Tools SA, is a Belgium- based company that develops products aimed to prevent negative response of the immune system.
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.